Top 4 Benefits of Site Management Organization
Numerous Pharma majors and CRO's, contract research organization, are taking the advantage of working with site management organizations for doing a more productive research and gaining cost advantage. Furthermore, site management organizations have played a key role in bridging the gap between the site and CRO, accelerating patient enrollment and taking the trials to the next level faster.
1. Rapid patient recruitment
One of the major benefits of site management organizations is the fact that the time taken for patient recruitment is considerably reduced. Add to that, the patient compliance throughout the study is also better due to efficient follow up by site management organization staff deployed at clinical research sites.
2. Cost and time savers
Without a doubt, a crucial benefit of site management organizations is that they can be cost and time savers for the sponsor companies and CRO's for properly initiating a multi-centric clinical trial.
3. Accurate and consistent documentation
It goes without saying, that site management organizations help in detailed as well as consistent documentation. In addition, these organizations also help in improving relationships with investigators.
4. Reduced study timelines
Another major benefit of site management organizations is the fact that they help in reducing study timelines due to quicker study start-up.
FOMAT Medical Research is a site management organization (SMO) with local CRO capabilities focused on the development and management of clinical trials in the USA and Latin America. You can visit the website at fomatmedical.com.
300th South Street A Suite 201 Oxnard, CA
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Top 4 Benefits of Site Management Organization here
News-ID: 546389 • Views: 170
More Releases from FOMAT Medical Research
Clinical Research in Ecuador - Diversity in Hispanic Community Involvement
Why is diversity important? FDA Action Plan In 2012 the Food and Drug Administration Safety and Innovation Act was published. Most of this FDA Action plan is based to encourage researchers to include safety and effectiveness data by demographic subgroups, including sex, age, race, and ethnicity. Section 907 of the FDA Safety and Innovation Act of 2012 also includes recommendations for improving the completeness and quality of analyses of data on demographic subgroups. In
More Releases for CRO
Imaging CRO Services Market: Competitive Dynamics & Global Outlook 2020-2025
Global Info Research offers a latest published report on Imaging CRO Services Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Imaging CRO Services Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure
Global CRO Services Market Size, Status and Forecast
This report studies the global CRO Services market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global CRO Services market by companies, region, type and end-use industry. Contract research organization (CRO) provide clinical trial and other research support services for the pharmaceutical, biotechnology, medical device industries and also serve government institutions, foundations and universities. Get sample copy of the report: www.marketdensity.com/contact?ref=Sample&reportid=75298 Table of Contents: Table of Contents Global
Global Contract Research Organization (CRO) Market Developments and Innovations …
Qyresearchreports include new market research report "Global Contract Research Organization (CRO) Market Size,Status and Forecast 2025" to its huge collection of research reports. Contract research organization (CRO) provide clinical trial and other research support services for the pharmaceutical, biotechnology, medical device industries and also serve government institutions, foundations and universities. CROs provide drug development services, regulatory and scientific support, and infrastructure and staffing support to provide their clients with the flexibility to
Global CRO Services Market Size, Status and Forecast 2022
This report studies the global CRO Services market, analyzes and researches the CRO Services development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Sino Biological Inc. HCL Technologies CTMG, Inc. Powered Research, LLC? Blue Sky BioServices Biomapas Integrated Resources Inc ICON Plc Celsion Labs? Sample of this report is available upon request @ http://www.qyresearchreports.com/sample/sample.php?rep_id=1310184&type=E Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by
CRO Services Industry Worldwide Growth and Development
ReportsWeb.com has announced the addition of the “Global CRO Services Market Size, Status and Forecast 2022” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. This report studies the global CRO Services market, analyzes and researches the CRO Services development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in
Partnership factors in sponsor – CRO relationships
Drugs discovered today can realistically cost upwards of 900 million dollars and around 12 years of development to reach a market. CRO’s have been increasingly used by larger pharma to outsource their clinical research, allowing big pharma to shut down in-house R&D, in practice saving money. There have been some issues however with the outsourcing of trials to CROs, including serious relationship break down with negative attitudes, failure to communicate